These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2735950)

  • 1. Partition of Ca2+ antagonists in brain plasma membranes.
    Carvalho CM; Oliveira CR; Lima MP; Leysen JE; Carvalho AP
    Biochem Pharmacol; 1989 Jul; 38(13):2121-7. PubMed ID: 2735950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers inhibit the (Ca2+ + Mg2+)-ATPase activity and the 125I-calmodulin binding in brain membranes.
    Santos DL; Lopes MC; Carvalho CM
    Eur J Pharmacol; 1994 May; 267(3):307-16. PubMed ID: 8088369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant effect of calcium antagonists on microsomal membranes isolated from different brain areas.
    Gonçalves T; Carvalho AP; Oliveira CR
    Eur J Pharmacol; 1991 Nov; 204(3):315-22. PubMed ID: 1773831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partition coefficients of dopamine antagonists in brain membranes and liposomes.
    Oliveira CR; Lima MC; Carvalho CA; Leysen JE; Carvalho AP
    Biochem Pharmacol; 1989 Jul; 38(13):2113-20. PubMed ID: 2735949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
    Homaidan FR; Donowitz M; Weiland GA; Sharp GW
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calciseptine binding to a 1,4-dihydropyridine recognition site of the L-type calcium channel of rat synaptosomal membranes.
    Yasuda O; Morimoto S; Chen Y; Jiang B; Kimura T; Sakakibara S; Koh E; Fukuo K; Kitano S; Ogihara T
    Biochem Biophys Res Commun; 1993 Jul; 194(2):587-94. PubMed ID: 8393668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic antidepressants and calcium channel blockers: interactions at the (-)-desmethoxyverapamil binding site and the serotonin transporter.
    Rehavi M; Carmi R; Weizman A
    Eur J Pharmacol; 1988 Oct; 155(1-2):1-9. PubMed ID: 2854066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities.
    Pang DC; Sperelakis N
    Biochem Pharmacol; 1984 Mar; 33(5):821-6. PubMed ID: 6608945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
    Haase H; Wallukat G; Vetter R; Will H
    Biomed Biochim Acta; 1987; 46(8-9):S363-9. PubMed ID: 2829862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG; Yamamura HI; Schoemaker H; Roeske WR
    J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.
    Spedding M; Mir AK
    Br J Pharmacol; 1987 Oct; 92(2):457-68. PubMed ID: 2445406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
    Mason RP; Moisey DM; Shajenko L
    Mol Pharmacol; 1992 Feb; 41(2):315-21. PubMed ID: 1531693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.
    Galizzi JP; Fosset M; Lazdunski M
    Biochem Biophys Res Commun; 1985 Oct; 132(1):49-55. PubMed ID: 2998366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ineffectiveness of organic calcium channel blockers in antagonizing long-term potentiation.
    Taube JS; Schwartzkroin PA
    Brain Res; 1986 Aug; 379(2):275-85. PubMed ID: 3017511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
    Bolger GT; Marcus KA; Daly JW; Skolnick P
    J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unitary mechanism of calcium antagonist drug action.
    Murphy KM; Gould RJ; Largent BL; Snyder SH
    Proc Natl Acad Sci U S A; 1983 Feb; 80(3):860-4. PubMed ID: 6572372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of a Ca2+/calmodulin-dependent binding of the Ca2+ channel antagonist, nitrendipine, to a postsynaptic density fraction isolated from canine cerebral cortex.
    Wu K; Sachs L; Carlin RK; Siekevitz P
    Brain Res; 1986 Nov; 387(2):167-84. PubMed ID: 3024780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.